Low-dose brain radiation improves behavior, cognition in Alzheimer’s pilot study
By
Alicia Lasek
May 04, 2021
Low-dose ionizing radiation may be a promising, although possibly controversial, therapy for Alzheimer’s disease, according to the researchers behind a small new pilot study.
Clinical briefs for Monday, Nov. 2
Nov 01, 2020
State stockpiling orders hurting nursing homes on PPE quest … Aspirin use best for those with high coronary calcium, low risk of bleeding … Myocarditis linked to COVID-19 not as common as believed:...
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...
CVS: Independent living residents will continue to wait for COVID-19 vaccination
By
Kimberly Bonvissuto
Jan 06, 2021
Independent living residents, even those who live in CCRCs, will have to continue to wait for COVID-19 vaccination, according to one of the retail giants administering the vaccines in long-term care.
Aduhelm’s costs: Medicare recipients won’t get premium reduction until 2023
By
Alicia Lasek (f3)
Jun 01, 2022
A cost overestimate that bumped up Medicare premiums for seniors in 2022 will not be corrected until the following year. The spike is tied to coverage for Alzheimer’s drug Aduhelm.
Long-term care risks extended negative image without more COVID data from operators: exec
By
James M. Berklan
Jun 16, 2020
Seniors housing and care providers across a wider spectrum must start submitting data to increase transparency about the effects of coronavirus infections, says NIC CEO Brian Jurutka.
Pfizer, BioNTech to pursue 2nd booster shot authorization for older adults
By
Alicia Lasek
Mar 16, 2022
A second booster — or fourth dose — will be necessary to improve the vaccine’s waning protection in the face of omicron, Pfizer’s CEO has stated. Whether the FDA will find the evidence compelling...
Omicron sub-variants cut potency of monoclonal antibodies, mRNA vaccines: study
Mar 04, 2022
Eli Lilly’s bebtelovimab is the only authorized monoclonal antibody that can neutralize all three dominant sub-variants, investigators say.
ADA: Diabetes may quadruple risk for long COVID
Jun 08, 2022
Diabetes may increase the risk for long COVID symptoms fourfold, according to research presented at the annual meeting of the American Diabetes Association.
Test twice? Antigen tests reach peak sensitivity 4 days in, study finds
By
Alicia Lasek (f3)
May 03, 2022
It may be best to repeat an early COVID-19 antigen test a day or two later when symptomatic individuals receive negative results, investigators say.